These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580 [TBL] [Abstract][Full Text] [Related]
5. Differential modulation of late sodium current by protein kinase A in R1623Q mutant of LQT3. Tsurugi T; Nagatomo T; Abe H; Oginosawa Y; Takemasa H; Kohno R; Makita N; Makielski JC; Otsuji Y Life Sci; 2009 Mar; 84(11-12):380-7. PubMed ID: 19167409 [TBL] [Abstract][Full Text] [Related]
6. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique. Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012 [TBL] [Abstract][Full Text] [Related]
7. Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide. Nagatomo T; January CT; Makielski JC Mol Pharmacol; 2000 Jan; 57(1):101-7. PubMed ID: 10617684 [TBL] [Abstract][Full Text] [Related]
9. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Wang DW; Yazawa K; George AL; Bennett PB Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568 [TBL] [Abstract][Full Text] [Related]
10. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3. Fabritz L; Damke D; Emmerich M; Kaufmann SG; Theis K; Blana A; Fortmüller L; Laakmann S; Hermann S; Aleynichenko E; Steinfurt J; Volkery D; Riemann B; Kirchhefer U; Franz MR; Breithardt G; Carmeliet E; Schäfers M; Maier SK; Carmeliet P; Kirchhof P Cardiovasc Res; 2010 Jul; 87(1):60-72. PubMed ID: 20110334 [TBL] [Abstract][Full Text] [Related]
11. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel. Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498 [TBL] [Abstract][Full Text] [Related]
12. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating. Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799 [TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: A computational analysis. Wehrens XH; Abriel H; Cabo C; Benhorin J; Kass RS Circulation; 2000 Aug; 102(5):584-90. PubMed ID: 10920073 [TBL] [Abstract][Full Text] [Related]
14. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Schwartz PJ; Priori SG; Locati EH; Napolitano C; Cantù F; Towbin JA; Keating MT; Hammoude H; Brown AM; Chen LS; Colatsky TJ Circulation; 1995 Dec; 92(12):3381-6. PubMed ID: 8521555 [TBL] [Abstract][Full Text] [Related]
15. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. Ma D; Wei H; Zhao Y; Lu J; Li G; Sahib NB; Tan TH; Wong KY; Shim W; Wong P; Cook SA; Liew R Int J Cardiol; 2013 Oct; 168(6):5277-86. PubMed ID: 23998552 [TBL] [Abstract][Full Text] [Related]
16. The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ Na Alvarez-Collazo J; López-Requena A; Alvarez JL; Talavera K Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599724 [TBL] [Abstract][Full Text] [Related]
17. Temperature dependence of early and late currents in human cardiac wild-type and long Q-T DeltaKPQ Na+ channels. Nagatomo T; Fan Z; Ye B; Tonkovich GS; January CT; Kyle JW; Makielski JC Am J Physiol; 1998 Dec; 275(6):H2016-24. PubMed ID: 9843800 [TBL] [Abstract][Full Text] [Related]
18. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation. Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo. Tian XL; Yong SL; Wan X; Wu L; Chung MK; Tchou PJ; Rosenbaum DS; Van Wagoner DR; Kirsch GE; Wang Q Cardiovasc Res; 2004 Feb; 61(2):256-67. PubMed ID: 14736542 [TBL] [Abstract][Full Text] [Related]
20. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome. Clancy CE; Tateyama M; Kass RS J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]